drugdeliverybusiness1d
Glooko announces CEO transition with $100M financing
Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO.
drugdeliverybusiness2d
Clearside Biomedical’s drug-device combo study meets endpoints
Clearside Biomedical today announced that the ODYSSEY study of its drug-device combination achieved its primary and secondary ...
drugdeliverybusiness4d
BD partners with ten23 health on prefilled syringe manufacturing
BD (NYSE:BDX) announced today that it entered into a collaboration with ten23 health to develop a new way to track ...
drugdeliverybusiness4d
Trinity Biotech completes pre-pivotal study of next-gen CGM
Trinity Biotech today announced that it completed the first pre-pivotal clinical trial in Europe for its next-generation CGM ...
drugdeliverybusiness4d
Medinol has first human implant of drug-eluting peripheral stent in Australia
Medinol today announced the successful first-in-human implantation of its ChampioNIR drug-eluting peripheral stent.
drugdeliverybusiness2d
NIH launches effort to combat type 2 diabetes in young people
The National Institutes of Health (NIH) launched a nationwide consortium to address the rise in youth diagnosed with type 2 ...
drugdeliverybusiness8d
ApiJect Systems promotes COO from within
Injection delivery system developer ApiJect announced that it promoted Molly Weaver to the position of chief operating officer. Weaver’s background includes both the pharmaceutical and medical ...
drugdeliverybusiness8d
Medtronic recalls some MiniMed automated insulin delivery systems with battery issues
The MiniMed 780G with the Guardian 4 sensor. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today announced a voluntary recall warning of battery issues with its MiniMed 600 and 700 series insulin ...